[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335952-105":59,"doc-detail-335952-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","ptch1-gene-variants-rs357564-rs2236405-rs2297086-and-rs41313327-mrna-and-tissue-expression-in-basal-cell-carcinoma-patients-from-western-mexico","PTCH1 gene variants rs357564, rs2236405, rs2297086 and rs41313327 - mRNA and tissue expression in basal cell carcinoma patients from Western Mexico","","Background: Basal cell carcinoma (BCC) accounts for about 80% of skin cancer cases. PTCH1, a transmembrane protein in the Sonic Hedgehog pathway, regulates cell proliferation and has been linked to BCC development. Methods: An analytical cross-sectional study evaluated 250 BCC patients and 290 controls from Western Mexico. Genotypes and relative mRNA expression were measured using a TaqMan assay, and PTCH1 protein expression was assessed by immunostaining in paraffin-embedded samples. Results: No significant association was found between PTCH1 variants rs357564, rs2297086, rs2236405, rs41313327 and BCC susceptibility, and no significant mRNA differences emerged. Protein expression was low in 6 samples and moderate in 1. Conclusion: The PTCH1 variants studied may not contribute to BCC in this population, with lower mRNA in patients but underexpression at the protein level in tissues.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/ptch1-gene-variants-rs357564-rs2236405-rs2297086-and-rs41313327-mrna-and-tissue-expression-in-basal-cell-carcinoma-patients-from-western-mexico/335952/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/ptch1-gene-variants-rs357564-rs2236405-rs2297086-and-rs41313327-mrna-and-tissue-expression-in-basal-cell-carcinoma-patients-from-western-mexico/335952.png","ImageObject",300,407,{"name":92,"@type":93},"Patrick","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Which PTCH1 genetic variants were investigated in basal cell carcinoma patients?","Question",{"text":112,"@type":113},"The study examined PTCH1 variants rs357564, rs2236405, rs2297086, and rs41313327 in patients from Western Mexico.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were PTCH1 mRNA and protein expression measured?",{"text":117,"@type":113},"PTCH1 mRNA expression was quantified using a TaqMan assay, while PTCH1 protein expression was evaluated in paraffin-embedded tissue samples using immunostaining with PTCH1 antibodies and semi-quantitative analysis.",{"name":119,"@type":110,"acceptedAnswer":120},"Did the PTCH1 variants show an association with basal cell carcinoma susceptibility?",{"text":121,"@type":113},"No evidence of an association was found between the studied PTCH1 variants and susceptibility to basal cell carcinoma in this population.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},335952,1790490853,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":4},549758146520,"https://ap-avatar.wpscdn.com/avatar/80002397d8c0411e94?_k=1775819394049821470","DOI: 10. 1002/jcla.25010  \nR E S E A RC H A RT I C L E  \nPTCH1 gene variants rs357564, rs2236405, rs2297086 and rs41313327, mRNA and tissue expression in basal cell carcinoma patients from Western Mexico  \nMarianela Zambrano-Román1,2  | Jorge R. Padilla-Gutiérrez1  | Yeminia Valle1  | José F. Muñoz-Valle1  | Elizabeth Guevara-Gutiérrez3  |  \nDiana Emilia Martínez-Fernández1  | Emmanuel Valdés-Alvarado1   \n1Centro Universitario de Ciencias dela Salud, Instituto de Investigación en Ciencias Biomédicas (IICB), Universidad de Guadalajara, Guadalajara, Mexico 2Doctorado en Genética Humana, Departamento de Biología Molecular y Genómica, Universidad de Guadalajara, Guadalajara, Mexico  \n3 Departamento de Dermatología, Instituto Dermatológico de Jalisco “Dr. José Barba Rubio”, Secretaría de Salud Jalisco, Zapopan, Jalisco, Mexico  \nCorrespondence  \nEmmanuel Valdés-Alvarado, Instituto de Investigación en Ciencias Biomédicas, Centro Universitario de Ciencias de la Salud, Guadalajara Jalisco, 44340, México. Email: emmanuel.valdes@academicos. [udg. mx](udg. mx)  \nFunding information  \nUniversidad de Guadalajara, Grant/Award Number: PIN 2020 CUCS-UDG  \nAbstract  \nBackground: Basal cell carcinoma (BCC) represents about 80% of all cases of skin cancer. The PTCH1 is a transmembrane protein of the Sonic Hedgehog signaling pathway that regulates cell proliferation. Genetic variants in PTCH1 gene have been previously described in association with BCC development. In addition, PTCH1 mRNA and protein expression analysis are also significant to understand its role in skin cancer physiopathology.  \nMethods: An analytical cross-sectional study was performed, and a total of 250 BCC patients and 290 subjects from the control group (CG) were included, all born in western Mexico. The genotypes and relative expression of the mRNA were determined by TaqMan® assay. The protein expression was investigated in 70 BCC paraffin-embedded samples with PTCH1 antibodies. Semi-quantitative analysis was performed to determine the expression level in the immunostained cells.  \nResults: We did not find evidence of an association between PTCH1 rs357564, rs2297086, rs2236405, and rs41313327 genetic variants and susceptibility to BCC. Likewise, no statistically significant differences were found in the comparison of the mRNA level expression between BCC and CG (p >0.05) . The PTCH1 protein showed a low expression in 6 of the analyzed samples and moderate expression in 1 sample. No association was found between genetic variants, protein expression, and demographic-clinical characteristics (p >0.05) .  \nConclusion: The studied PTCH1 variants may not be associated with BCC development in the Western Mexico population. The PTCH1 mRNA levels were lower in patients with BCC compared to the control group, but its protein was underexpressed in the tissue samples.  \nK E Y WO R D S  \nbasal cell carcinoma, genetic variants, mRNA, protein expression, PTCH1  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \n© 2024 The Authors. Journal of Clinical Laboratory Analysis published by Wiley Periodicals LLC.  \nJ Clin Lab Anal. 2024;38:e25010 .  \n[https://doi.org/10.1002/jcla.25010](https://doi.org/10.1002/jcla.25010)  \n[wileyonlinelibrary.com/journal/jcla](wileyonlinelibrary.com/journal/jcla)  \n1 of 9  \n1 | INTRODUCTION  \nNon-melanoma skin cancer (NMSC) represents almost 90% of all cutaneous neoplasms, with more than one million cases per year.1,2 Basal Cell Carcinoma (BCC) has the highest prevalence in the NMSC group, which accounts for about 80% of these tumors worldwide, and its incidence keeps rising by nearly 10% each year.3 Even though the cancer hallmarks have been broadly defined, the main leading risk factor for developing skin cancer is solar ultraviolet radiation (UVR), which affects the DNA of the cells in the skin epithelium.4,","cbCaijALUR4H8IlM","https://ap.wps.com/l/cbCaijALUR4H8IlM","pdf",1774821,"English","# Introduction\n## PTCH1 and BCC background\n## Study rationale\n# Materials and Methods\n## Subjects","[{\"question\":\"Which PTCH1 genetic variants were investigated in basal cell carcinoma patients?\",\"answer\":\"The study examined PTCH1 variants rs357564, rs2236405, rs2297086, and rs41313327 in patients from Western Mexico.\"},{\"question\":\"How were PTCH1 mRNA and protein expression measured?\",\"answer\":\"PTCH1 mRNA expression was quantified using a TaqMan assay, while PTCH1 protein expression was evaluated in paraffin-embedded tissue samples using immunostaining with PTCH1 antibodies and semi-quantitative analysis.\"},{\"question\":\"Did the PTCH1 variants show an association with basal cell carcinoma susceptibility?\",\"answer\":\"No evidence of an association was found between the studied PTCH1 variants and susceptibility to basal cell carcinoma in this population.\"}]","PTCH1 gene variants rs357564, rs2236405, rs2297086 and rs41313327 - mRNA and tissue expression in basal cell carcinoma patients from Western Mexico | PDF",1790012918,23]